| 129.61 0.06 (0.05%) | 10-28 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 157.2 | 1-year : | 183.61 |
| Resists | First : | 134.58 | Second : | 157.2 |
| Pivot price | 127.18  |
|||
| Supports | First : | 127.38 | Second : | 122.93 |
| MAs | MA(5) : | 129.08 |
MA(20) : | 128.15 |
| MA(100) : | 135.67 |
MA(250) : | 145.54 |
|
| MACD | MACD : | -0.8 |
Signal : | -1.4 |
| %K %D | K(14,3) : | 74.9 |
D(3) : | 66.2 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 179.6 | Low : | 122.93 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DVA ] has closed below upper band by 17.3%. Bollinger Bands are 33.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 130.91 - 131.41 | 131.41 - 131.92 |
| Low: | 126.95 - 127.56 | 127.56 - 128.16 |
| Close: | 128.63 - 129.56 | 129.56 - 130.49 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Tue, 28 Oct 2025
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - Insider Monkey
Tue, 28 Oct 2025
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - Yahoo
Tue, 28 Oct 2025
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? - sharewise.com
Tue, 28 Oct 2025
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? - Zacks Investment Research
Mon, 27 Oct 2025
DaVita (DVA) Reports Q3: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Wed, 22 Oct 2025
DaVita (DVA): Assessing Valuation in Light of New Dialysis Research Initiatives - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 72 (M) |
| Shares Float | 36 (M) |
| Held by Insiders | 49.9 (%) |
| Held by Institutions | 51.1 (%) |
| Shares Short | 6,520 (K) |
| Shares Short P.Month | 7,510 (K) |
| EPS | 10.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -4.99 |
| Profit Margin | 6.3 % |
| Operating Margin | 15.6 % |
| Return on Assets (ttm) | 7.1 % |
| Return on Equity (ttm) | 57.9 % |
| Qtrly Rev. Growth | 6 % |
| Gross Profit (p.s.) | 59.86 |
| Sales Per Share | 184.05 |
| EBITDA (p.s.) | 37.62 |
| Qtrly Earnings Growth | 3.2 % |
| Operating Cash Flow | 1,860 (M) |
| Levered Free Cash Flow | 1,100 (M) |
| PE Ratio | 12.76 |
| PEG Ratio | 0 |
| Price to Book value | -26.03 |
| Price to Sales | 0.7 |
| Price to Cash Flow | 4.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|